1.Association between maximal urethral length preservation and postoperative continence after robot-assisted radical prostatectomy: a meta-analysis and systematic review.
Tian-Yu XIONG ; Zhan-Liang LIU ; Hao-Yu WU ; Yun-Peng FAN ; Yi-Nong NIU
Asian Journal of Andrology 2025;27(2):225-230
Urinary incontinence is a common complication following robot-assisted radical prostatectomy (RARP). Urethral length has been identified as a factor affecting postoperative continence recovery. In this meta-analysis, we examined the association between use of the maximal urethral length preservation (MULP) technique and postoperative urinary continence in patients undergoing RARP. We conducted a comprehensive search of PubMed, Web of Science, Embase, and the Cochrane Library up to December 31, 2023. The quality of the literature was assessed using the Newcastle-Ottawa Scale. A random-effects meta-analysis was performed to synthesize data and calculate the odds ratio (OR) from eligible studies on continence and MULP. Six studies involving 1869 patients met the eligibility criteria. MULP was positively associated with both early continence (1 month after RARP; Z = 3.62, P = 0.003, OR = 3.10, 95% confidence interval [CI]: 1.68-5.73) and late continence (12 months after RARP; Z = 2.34, P = 0.019, OR = 2.10, 95% CI: 1.13-3.90). Oncological outcomes indicated that MULP did not increase the overall positive surgical margin rate or the positive surgical margin status at the prostate apex (both P > 0.05). In conclusion, the use of the MULP technique in RARP significantly improved both early and late postoperative continence outcomes without compromising oncological outcomes.
Humans
;
Prostatectomy/adverse effects*
;
Robotic Surgical Procedures/methods*
;
Male
;
Urethra/surgery*
;
Urinary Incontinence/prevention & control*
;
Postoperative Complications/etiology*
;
Prostatic Neoplasms/surgery*
;
Organ Sparing Treatments/methods*
2.Influencing factors of lower urinary tract symptoms in patients after radical prostatectomy and nursing strategy.
Na YU ; Song XU ; Hao-Wei HE ; Dian FU ; Tian-Yi SHEN ; Meng ZHANG
National Journal of Andrology 2025;31(9):818-822
OBJECTIVE:
This study aims to analyze the influence factors of lower urinary tract symptoms (LUTS) in patients receiving radical prostatectomy for prostate cancer, and to explore effective nursing strategy in order to provide a theoretical basis for improving the postoperative quality of life of patients.
METHODS:
A retrospective study was conducted on 103 elderly male patients who underwent radical prostatectomy for prostate cancer in the Department of Urology at General Hospital of Eastern Theater Command from August 2022 to August 2024. The patients were categorized into two groups based on whether LUTS occurred. Demographic and clinical characteristics, perioperative parameters, follow-up data, and participation in pelvic floor muscle training were analyzed to identify risk factors associated with postoperative LUTS.
RESULTS:
The incidence of postoperative LUTS in the patients with LUTS before the operation was significantly higher than that in the patients without LUTS before the operation (68.42% vs 32.61%, P=0.001). Additionally, the use of larger catheters (22F) was closely associated with an increased incidence of postoperative LUTS(P<0.01). Pelvic floor exercises demonstrated a significant protective effect, with patients who engaged in pelvic floor exercises exhibiting a lower incidence of postoperative LUTS (38.60% vs 60.87%, P=0.040). Regression analysis further revealed that pelvic floor exercises was the protective factor for postoperative LUTS (OR=0.215, 95%CI: 0.091-0.508, P<0.01).
CONCLUSION
Preoperative LUTS and catheter size are significant risk factors for the occurrence of postoperative LUTS following radical prostatectomy. Pelvic floor muscle exercise after surgery has a protective effect. Postoperative personalized nursing interventions are necessary for different patients to achieve optimal recovery outcomes.
Humans
;
Male
;
Prostatectomy/adverse effects*
;
Retrospective Studies
;
Lower Urinary Tract Symptoms/nursing*
;
Aged
;
Risk Factors
;
Quality of Life
;
Pelvic Floor
;
Prostatic Neoplasms/surgery*
;
Postoperative Complications/prevention & control*
;
Exercise Therapy
;
Middle Aged
3.Human microbiome and prostate cancer development: current insights into the prevention and treatment.
Solmaz OHADIAN MOGHADAM ; Seyed Ali MOMENI
Frontiers of Medicine 2021;15(1):11-32
The huge communities of microorganisms that symbiotically colonize humans are recognized as significant players in health and disease. The human microbiome may influence prostate cancer development. To date, several studies have focused on the effect of prostate infections as well as the composition of the human microbiome in relation to prostate cancer risk. Current studies suggest that the microbiota of men with prostate cancer significantly differs from that of healthy men, demonstrating that certain bacteria could be associated with cancer development as well as altered responses to treatment. In healthy individuals, the microbiome plays a crucial role in the maintenance of homeostasis of body metabolism. Dysbiosis may contribute to the emergence of health problems, including malignancy through affecting systemic immune responses and creating systemic inflammation, and changing serum hormone levels. In this review, we discuss recent data about how the microbes colonizing different parts of the human body including urinary tract, gastrointestinal tract, oral cavity, and skin might affect the risk of developing prostate cancer. Furthermore, we discuss strategies to target the microbiome for risk assessment, prevention, and treatment of prostate cancer.
Bacteria
;
Dysbiosis
;
Humans
;
Male
;
Microbiota
;
Prostatic Neoplasms/prevention & control*
4.Vitamin D in prostate cancer.
Donald L TRUMP ; Jeanny B ARAGON-CHING
Asian Journal of Andrology 2018;20(3):244-252
Signaling through the vitamin D receptor has been shown to be biologically active and important in a number of preclinical studies in prostate and other cancers. Epidemiologic data also indicate that vitamin D signaling may be important in the cause and prognosis of prostate and other cancers. These data indicate that perturbation of vitamin D signaling may be a target for the prevention and treatment of prostate cancer. Large studies of vitamin D supplementation will be required to determine whether these observations can be translated into prevention strategies. This paper reviews the available data in the use of vitamin D compounds in the treatment of prostate cancer. Clinical data are limited which support the use of vitamin D compounds in the management of men with prostate cancer. However, clinical trials guided by existing preclinical data are limited.
Antineoplastic Combined Chemotherapy Protocols/therapeutic use*
;
Calcifediol/blood*
;
Calcitriol/therapeutic use*
;
Clinical Trials as Topic
;
Ergocalciferols/therapeutic use*
;
Humans
;
Male
;
Prostatic Neoplasms/prevention & control*
;
Signal Transduction
;
Vitamin D/metabolism*
;
Vitamin D Deficiency/epidemiology*
5.Prostate Cancer Prevention Trial risk calculator for evaluating the risk of prostate cancer in the high-risk Chinese population.
Xiao-Dong ZHU ; An ZHENG ; Zhi-Qian WANG ; Qiang SHAO
National Journal of Andrology 2018;24(2):142-146
Objective:
The Prostate Cancer Prevention Trial risk calculator (PCPT-RC) is an online tool for assessing the risk of prostate cancer (PCa) based on age, race, serum PSA, biopsy history, family history, and other factors. This study aimed to investigate the value, sensitivity and specificity of the PCPT-RC 2.0 in assessing the risk of PCa in the Chinese high-risk population.
METHODS:
This study included 622 patients with the high risk of PCa characterized by high serum PSA (PSA >3 μg/L) or abnormality in digital rectal examination or imaging of the prostate. According to the results of prostate biopsy, we divided the patients into a PCa and a non-PCa group and used the PCPT-RC 2.0 for evaluation of all the cases followed by statistical analysis.
RESULTS:
PCa was detected in 264 (42.4%) of the 622 patients, including 126 cases of high-grade malignancy. Compared with the non-PCa group, the PCa patients showed a significantly older age ([68.40 ± 7.30] vs [72.80 ± 7.20] yr, P <0.001), higher serum PSA level ([11.20 ± 7.76] vs [15.06 ± 10.65], P <0.001), and higher PCPT risk score ([37.0 ± 10.8]% vs [44.4 ± 12.6]%, P <0.001). The PCPT risk score exhibited a greater area under the ROC curve than the level of serum PSA in evaluating the risk of PCa (0.67 vs 0.61, P <0.05), but no statistically significant difference between the two in predicting the risk of high-grade malignancy (0.67 vs 0.66, P >0.05).
CONCLUSIONS
The PCPT risk score is valuable in predicting the risk of PCa in China, which may play a better role than the serum PSA level in screening PCa and avoid unnecessary prostate biopsy, though its advantage is not so obvious in identifying high-grade malignancy. A prediction tool needs to be established for evaluating the risk of PCa in the Chinese population.
Age Factors
;
Aged
;
Asian Continental Ancestry Group
;
Biopsy
;
China
;
Continental Population Groups
;
Digital Rectal Examination
;
Humans
;
Male
;
Prostate
;
pathology
;
Prostate-Specific Antigen
;
blood
;
Prostatic Neoplasms
;
blood
;
pathology
;
prevention & control
;
ROC Curve
;
Risk Assessment
;
methods
;
Risk Factors
6.Nursing care of prostate cancer patients against radiative proctitisinduced by CyberKnife treatment.
Ao-Mei LI ; Jie GAO ; Kai-Yu LU ; Sheng-Yuan ZHANG
National Journal of Andrology 2017;23(1):69-72
Objective:
To investigate the nursing care of prostate cancer (PCa) patients againstradioactive proctitisinduced byCyberKnifetreatment.
METHODS:
Sixty-eightPCapatients undergoingCyberKnife treatment in the observation group receivedspecialnursing care againstradioactive proctitis. The nursing measures includedthoserelevant toCyberKnife treatment, prevention ofradioactive proctitis, skin care, and discharge guidance. Meanwhile, another 54 prostate cancer patients received traditional nursing care as controls. We compared the incidence rate and severity of radioactive proctitis between the two groups of patients.
RESULTS:
The incidence rate of radioactive proctitiswas markedly lower in the observation group than in the control (2.9% vs 13.0%, P<0.05), but no statistically significant difference was observed in the severity of radioactive proctitis between the two groups of patients.
CONCLUSIONS
The special nursing care againstCyberKnife-induced radioactiveproctitiscan significantlyreduce the incidence of radioactive proctitis andimprove the effect of CyberKnife treatment of prostate cancer, which therefore deserves wide clinical application.
Case-Control Studies
;
Humans
;
Male
;
Proctitis
;
etiology
;
nursing
;
prevention & control
;
Prostatic Neoplasms
;
radiotherapy
;
Radiation Injuries
;
nursing
;
prevention & control
;
Radiosurgery
;
adverse effects
7.Gene regulation of prostaglandin synthase and prostate diseases.
Shuang-Shuang WU ; Jian-Hui WU ; Zu-Yue SUN
National Journal of Andrology 2017;23(7):663-667
Prostaglandin synthase (PGS) can catalyze the production of various types of prostaglandins and regulate the expression levels of related substances. The regulation mechanisms of the PGS gene are closely related with the occurrence and development of prostate diseases. However, few studies are reported on the regulation mechanisms of PGS in prostatic diseases, such as benign prostatic hyperplasia (BPH) and prostate cancer (PCa), or on the relationship between PGS gene regulation and prostate diseases. This review aims to analyze their correlation and provide some ideas for the prevention and control of BPH and PCa by intervention of the prostaglandin synthase regulatory pathway.
Gene Expression Regulation
;
Humans
;
Male
;
Prostaglandin-Endoperoxide Synthases
;
genetics
;
physiology
;
Prostatic Hyperplasia
;
enzymology
;
genetics
;
prevention & control
;
Prostatic Neoplasms
;
enzymology
;
genetics
;
prevention & control
8.Prevention and treatment of erectile dysfunction after prostatectomy: An update.
National Journal of Andrology 2017;23(7):656-662
Prostate cancer has the highest incidence among malignant tumors of the urinary system in China. Radical prostatectomy (RP) is the most effective treatment for localized prostate cancer with a good long-term prognosis. Erectile dysfunction (ED) is a common complication after RP, which seriously affects the patient's quality of life. With the rising incidence and early diagnosis of prostate cancer, the proportion of young cases of RP is increasing, and so is the importance of the treatment of post-RP ED. The restoration of erectile function after RP is closely related to the timing of penile rehabilitation as well as to pre- and intra-operative measures such as surgical strategies and methods. Common options for the treatment of post-RP ED include oral medication of phosphodiesterase type 5 inhibitors, application of vasoactive substances in the urethra or corpus cavernosum, use of vacuum erection devices, and implantation of penile prosthesis. Stem cell therapy, nerve transplantation, low-intensity extracorporeal shockwave therapy, and erythropoietin have shown great potential in penile rehabilitation after RP. At present, the stress is placed on the remission of symptoms in the treatment of ED. Stem cell therapy may reverse the cause of disease or cure ED by reversing its pathophysiological changes. A series of clinical trials of stem cell therapy are underway and have preliminarily confirmed the safety of stem cell therapy and proved that it can improve erectile function in patients with post-RP ED. This review focuses on the progress in the prevention and treatment of ED after RP.
China
;
Erectile Dysfunction
;
prevention & control
;
therapy
;
Humans
;
Male
;
Penile Erection
;
Penile Prosthesis
;
Phosphodiesterase 5 Inhibitors
;
therapeutic use
;
Postoperative Complications
;
prevention & control
;
therapy
;
Prostatectomy
;
adverse effects
;
Prostatic Neoplasms
;
surgery
;
Quality of Life
;
Stem Cell Transplantation
;
Treatment Outcome
;
Vacuum
;
Vasodilator Agents
;
therapeutic use
9.One-puncture one-needle TRUS-guided prostate biopsy for prevention of postoperative infections.
Xiao-Fu QIU ; Guo-Sheng YANG ; Bo-Te CHEN ; Li MA
National Journal of Andrology 2017;23(7):630-634
Objective:
To explore the feasibility and effectiveness of "one-puncture one-needle" transrectal ultrasound (TRUS)-guided prostate biopsy in the prevention of postoperative infections.
METHODS:
We retrospectively analyzed the clinical data about "one-puncture one-needle" (the observation group) and "one-person one-needle" (the control group) TRUS-guided prostate biopsy performed in the Second People's Hospital of Guangdong Province from January 2005 to December 2015, and compared the incidence rates of puncture-related infection between the two strategies. By "one-puncture one-needle", one needle was used for one biopsy puncture, while by "one-person one-needle", one needle was used for all biopsy punctures in one patient and the needle was sterilized with iodophor after each puncture.
RESULTS:
Totally, 120 patients received 6+1-core or 12+1-core "one-person one-needle" and 466 underwent 12+1-core "one-puncture one-needle" TRUS-guided prostate biopsy. There were no statistically significant differences between the two groups of patients in age, the prostate volume, the serum PSA level, or the detection rate of prostate cancer (P >0.05). Compared with the control group, the observation group showed remarkably lower incidence rates of puncture-related urinary tract infection (7.5% vs 0.9%, P <0.05), fever (5.0% vs 1.1%, P <0.05), bacteriuria (2.5% vs 0.2%, P <0.05), and total infections (16.7% vs 2.6%, P<0.05) postoperatively. Two cases of bacteremia or sepsis were found in each of the groups, with no significant difference between the two.
CONCLUSIONS
"One-puncture one-needle" TRUS-guided prostate biopsy can effectively prevent puncture-related infections.
Bacteremia
;
etiology
;
Biopsy, Fine-Needle
;
adverse effects
;
instrumentation
;
methods
;
Case-Control Studies
;
Feasibility Studies
;
Humans
;
Male
;
Prostate
;
pathology
;
Prostate-Specific Antigen
;
blood
;
Prostatic Neoplasms
;
blood
;
pathology
;
Retrospective Studies
;
Sterilization
;
methods
;
Ultrasonography, Interventional
;
Urinary Tract Infections
;
prevention & control
10.News Portrayal of Cancer: Content Analysis of Threat and Efficacy by Cancer Type and Comparison with Incidence and Mortality in Korea.
Minsun SHIM ; Yong Chan KIM ; Su Yeon KYE ; Keeho PARK
Journal of Korean Medical Science 2016;31(8):1231-1238
How the news media cover cancer may have profound significance for cancer prevention and control; however, little is known about the actual content of cancer news coverage in Korea. This research thus aimed to examine news portrayal of specific cancer types with respect to threat and efficacy, and to investigate whether news portrayal corresponds to actual cancer statistics. A content analysis of 1,138 cancer news stories was conducted, using a representative sample from 23 news outlets (television, newspapers, and other news media) in Korea over a 5-year period from 2008 to 2012. Cancer incidence and mortality rates were obtained from the Korean Statistical Information Service. Results suggest that threat was most prominent in news stories on pancreatic cancer (with 87% of the articles containing threat information with specific details), followed by liver (80%) and lung cancers (70%), and least in stomach cancer (41%). Efficacy information with details was conveyed most often in articles on colorectal (54%), skin (54%), and liver (50%) cancers, and least in thyroid cancer (17%). In terms of discrepancies between news portrayal and actual statistics, the threat of pancreatic and liver cancers was overreported, whereas the threat of stomach and prostate cancers was underreported. Efficacy information regarding cervical and colorectal cancers was overrepresented in the news relative to cancer statistics; efficacy of lung and thyroid cancers was underreported. Findings provide important implications for medical professionals to understand news information about particular cancers as a basis for public (mis)perception, and to communicate effectively about cancer risk with the public and patients.
Communication
;
Humans
;
Incidence
;
Internet/statistics & numerical data
;
Liver Neoplasms/epidemiology
;
Male
;
Mass Media/*statistics & numerical data
;
Neoplasms/*epidemiology/mortality/prevention & control
;
Pancreatic Neoplasms/epidemiology
;
Prostatic Neoplasms/epidemiology
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Stomach Neoplasms/epidemiology

Result Analysis
Print
Save
E-mail